These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8549952)

  • 1. Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.
    Yokosuka O; Kato N; Hosoda K; Ito Y; Imazeki F; Ohto M; Omata M
    Gut; 1995 Nov; 37(5):721-6. PubMed ID: 8549952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
    Kakumu S; Yoshika K; Tanaka K; Higashi Y; Kurokawa S; Hirofuji H; Kusakabe A
    J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
    Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
    Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
    Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
    Shindo M; Di Bisceglie AM; Cheung L; Shih JW; Cristiano K; Feinstone SM; Hoofnagle JH
    Ann Intern Med; 1991 Nov; 115(9):700-4. PubMed ID: 1656828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of serum hepatitis C virus levels in patients with chronic hepatitis C treated with two courses of interferon administration.
    Saitoh Y; Miura M; Niitsuma H; Numata N; Ohori H; Ishii M; Toyota T
    Tohoku J Exp Med; 1994 Aug; 173(4):361-9. PubMed ID: 7529950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion.
    Hosoda K; Yokosuka O; Kato N; Ito Y; Ohto M; Omata M
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():115-7. PubMed ID: 8395437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
    Calleja JL; Albillos A; Cacho G; Iborra J; Abreu L; Escartín P
    J Hepatol; 1996 Mar; 24(3):308-12. PubMed ID: 8778197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
    Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
    J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mooren-type hepatitis C virus-associated corneal ulceration.
    Wilson SE; Lee WM; Murakami C; Weng J; Moninger GA
    Ophthalmology; 1994 Apr; 101(4):736-45. PubMed ID: 7512254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
    Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
    J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV RNA in patients with chronic hepatitis C treated with interferon-alpha.
    Liang TJ; Rustgi V; Galun E; Blum HE
    J Med Virol; 1993 May; 40(1):69-75. PubMed ID: 8390560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha.
    Hagiwara H; Hayashi N; Mita E; Ueda K; Takehara T; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1992 Jan; 15(1):37-41. PubMed ID: 1370161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
    Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
    Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
    Carreño V; Tapia L; Ryff JC; Quiroga JA; Castillo I
    J Med Virol; 1992 Jul; 37(3):215-9. PubMed ID: 1331310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis D with interferon alfa-2a.
    Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D
    N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.